Hereditary angioedema: Its diagnostic and management perspectives

Tommy C. Sim, J. Andrew Grant

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Although hereditary angioedema accounts for only a small fraction of all cases of angioedema, it is the most common genetically linked clinical disorder caused by the deficiency of a protein associated with complement activation. Attacks may be complicated by incapacitating cutaneous swelling, life-threatening upper airway impediment, and severe gastrointestinal colic. Recent physicochemical and genetic studies have contributed significantly to our understanding of the structure of the inhibitor protein. Measurement of serum C4 titer is an efficacious screening test. Normal levels during symptomatic periods rule out the diagnosis, whereas decreased levels warrant determination of C1 esterase inhibitor titer by immunoassay or functional assay. The functional assay is necessary to ascertain the genetic variant form. The importance of making the correct diagnosis cannot be overemphasized. It can avert potentially fatal consequences, such as upper airway obstruction and unnecessary abdominal surgery. The application of short-term preventive measures can avoid complications associated with trauma. Finally, abatement or elimination of symptoms in patients with incessant and disabling attacks can be attained by long-term therapy with currently available attenuated androgens.

Original languageEnglish (US)
Pages (from-to)656-664
Number of pages9
JournalThe American Journal of Medicine
Volume88
Issue number6
DOIs
StatePublished - 1990

Fingerprint

Hereditary Angioedemas
Complement C1 Inhibitor Protein
Unnecessary Procedures
Protein Deficiency
Angioedema
Colic
Complement Activation
Airway Obstruction
Immunoassay
Androgens
Skin
Wounds and Injuries
Serum
Proteins
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Hereditary angioedema : Its diagnostic and management perspectives. / Sim, Tommy C.; Andrew Grant, J.

In: The American Journal of Medicine, Vol. 88, No. 6, 1990, p. 656-664.

Research output: Contribution to journalArticle

Sim, Tommy C. ; Andrew Grant, J. / Hereditary angioedema : Its diagnostic and management perspectives. In: The American Journal of Medicine. 1990 ; Vol. 88, No. 6. pp. 656-664.
@article{22430ca04ea94db39c024062b0445980,
title = "Hereditary angioedema: Its diagnostic and management perspectives",
abstract = "Although hereditary angioedema accounts for only a small fraction of all cases of angioedema, it is the most common genetically linked clinical disorder caused by the deficiency of a protein associated with complement activation. Attacks may be complicated by incapacitating cutaneous swelling, life-threatening upper airway impediment, and severe gastrointestinal colic. Recent physicochemical and genetic studies have contributed significantly to our understanding of the structure of the inhibitor protein. Measurement of serum C4 titer is an efficacious screening test. Normal levels during symptomatic periods rule out the diagnosis, whereas decreased levels warrant determination of C1 esterase inhibitor titer by immunoassay or functional assay. The functional assay is necessary to ascertain the genetic variant form. The importance of making the correct diagnosis cannot be overemphasized. It can avert potentially fatal consequences, such as upper airway obstruction and unnecessary abdominal surgery. The application of short-term preventive measures can avoid complications associated with trauma. Finally, abatement or elimination of symptoms in patients with incessant and disabling attacks can be attained by long-term therapy with currently available attenuated androgens.",
author = "Sim, {Tommy C.} and {Andrew Grant}, J.",
year = "1990",
doi = "10.1016/0002-9343(90)90535-L",
language = "English (US)",
volume = "88",
pages = "656--664",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Hereditary angioedema

T2 - Its diagnostic and management perspectives

AU - Sim, Tommy C.

AU - Andrew Grant, J.

PY - 1990

Y1 - 1990

N2 - Although hereditary angioedema accounts for only a small fraction of all cases of angioedema, it is the most common genetically linked clinical disorder caused by the deficiency of a protein associated with complement activation. Attacks may be complicated by incapacitating cutaneous swelling, life-threatening upper airway impediment, and severe gastrointestinal colic. Recent physicochemical and genetic studies have contributed significantly to our understanding of the structure of the inhibitor protein. Measurement of serum C4 titer is an efficacious screening test. Normal levels during symptomatic periods rule out the diagnosis, whereas decreased levels warrant determination of C1 esterase inhibitor titer by immunoassay or functional assay. The functional assay is necessary to ascertain the genetic variant form. The importance of making the correct diagnosis cannot be overemphasized. It can avert potentially fatal consequences, such as upper airway obstruction and unnecessary abdominal surgery. The application of short-term preventive measures can avoid complications associated with trauma. Finally, abatement or elimination of symptoms in patients with incessant and disabling attacks can be attained by long-term therapy with currently available attenuated androgens.

AB - Although hereditary angioedema accounts for only a small fraction of all cases of angioedema, it is the most common genetically linked clinical disorder caused by the deficiency of a protein associated with complement activation. Attacks may be complicated by incapacitating cutaneous swelling, life-threatening upper airway impediment, and severe gastrointestinal colic. Recent physicochemical and genetic studies have contributed significantly to our understanding of the structure of the inhibitor protein. Measurement of serum C4 titer is an efficacious screening test. Normal levels during symptomatic periods rule out the diagnosis, whereas decreased levels warrant determination of C1 esterase inhibitor titer by immunoassay or functional assay. The functional assay is necessary to ascertain the genetic variant form. The importance of making the correct diagnosis cannot be overemphasized. It can avert potentially fatal consequences, such as upper airway obstruction and unnecessary abdominal surgery. The application of short-term preventive measures can avoid complications associated with trauma. Finally, abatement or elimination of symptoms in patients with incessant and disabling attacks can be attained by long-term therapy with currently available attenuated androgens.

UR - http://www.scopus.com/inward/record.url?scp=0025316886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025316886&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(90)90535-L

DO - 10.1016/0002-9343(90)90535-L

M3 - Article

C2 - 2189311

AN - SCOPUS:0025316886

VL - 88

SP - 656

EP - 664

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 6

ER -